Comparison in Efficacy of Misoprostol and uterine- Foley- Balloon Tamponade in Postpartum Haemorrhage
DOI:
https://doi.org/10.70749/ijbr.v3i7.2299Keywords:
Balloon Tamponade, Misoprostol, Postpartum Hemorrhage, Randomized Controlled Trial, Uterine Atony.Abstract
Background: Postpartum hemorrhage remains one of the leading causes of maternal morbidity and mortality, especially in low-resource settings. Misoprostol and uterine Foley balloon tamponade are widely used therapeutic approaches, but limited data exist from Azad Kashmir regarding their comparative effectiveness. Objective: To compare the efficacy of misoprostol versus uterine Foley balloon tamponade among pregnant women in management of post-partum haemorrhage. Study Design: Randomized controlled trial. Duration and Place of Study: This study was conducted at the Department of Obstetrics and Gynecology, CMH Rawalakot, from December 2024 to May 2025. Methodology: A total of 206 women aged 18–45 years presenting with primary PPH were enrolled and randomly assigned to two equal groups. Group A received 1000 µg misoprostol per rectum, while Group B was managed with uterine Foley balloon tamponade. Demographic and clinical data, including parity, gestational age, blood loss, delivery type, and neonatal weight, were recorded. Treatment was considered successful if bleeding was controlled without further complications. Results: The mean age of participants was 33.41±7.50 years in the misoprostol group and 30.86±7.79 years in the Foley balloon group. Misoprostol achieved efficacy in 88.3% of patients, while the Foley balloon was effective in 81.6% (p=0.173). Conclusion: Both misoprostol and uterine Foley balloon tamponade demonstrated comparable efficacy in controlling PPH, making them viable options in resource-constrained clinical environments.
Downloads
References
1. Patel, M. (2024). Postpartum hemorrhage: Enhancing outcomes for mothers by effective management. The Journal of Obstetrics and Gynecology of India, 74(3), 191-195.
https://doi.org/10.1007/s13224-024-02022-3
2. Bienstock, J. L., Eke, A. C., & Hueppchen, N. A. (2021). Postpartum hemorrhage. New England Journal of Medicine, 384(17), 1635-1645.
https://doi.org/10.1056/nejmra1513247
3. Aimagambetova, G., Bapayeva, G., Sakhipova, G., & Terzic, M. (2024). Management of postpartum hemorrhage in low- and middle-income countries: Emergency need for updated approach due to specific circumstances, resources, and availabilities. Journal of Clinical Medicine, 13(23), 7387.
https://doi.org/10.3390/jcm13237387
4. Akter, S., Forbes, G., Vazquez Corona, M., Miller, S., Althabe, F., Coomarasamy, A., Gallos, I. D., Oladapo, O. T., Vogel, J. P., Lorencatto, F., & Bohren, M. A. (2023). Perceptions and experiences of the prevention, detection, and management of postpartum haemorrhage: A qualitative evidence synthesis. Cochrane Database of Systematic Reviews, 2023(11).
https://doi.org/10.1002/14651858.cd013795.pub2
5. Wang, M. J., & Oyelese, Y. (2024). Postpartum hemorrhage. Maternal-Fetal Medicine, 7(1), 38-48.
https://doi.org/10.1097/fm9.0000000000000261
6. Sringamwong, W., Saokaew, S., & Mongkhon, P. (2022). Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial. Annals of Medicine & Surgery, 78.
https://doi.org/10.1016/j.amsu.2022.103931
7. Atef, A., Shehata, H. S., Bassiouny, Y. A., & Al-Inany, H. G. (2024). Comparative study between the roles of intrauterine misoprostol versus the sublingual route for prevention of postpartum blood loss in elective cesarean sections: A randomized controlled trial. BMC Pregnancy and Childbirth, 24(1).
https://doi.org/10.1186/s12884-024-06889-y
8. Salari, A., Pourrajabi, A., Karami, S., & Hamidi Madani, Z. (2023). Reactions to Misoprostol: A case report. Clinical Medicine Insights: Case Reports, 16.
https://doi.org/10.1177/11795476231215903
9. Purandare, C. N., Nazareth, A. K., Ryan, G., & Purandare, N. C. (2022). Role of balloon tamponade as a therapeutic non-surgical tool in controlling obstetric and Gynecological hemorrhage in low-resource countries. The Journal of Obstetrics and Gynecology of India, 72(4), 285-290.
https://doi.org/10.1007/s13224-022-01662-7
10. Weeks, A. D., Akinola, O. I., Amorim, M., Carvalho, B., Deneux-Tharaux, C., Liabsuetrakul, T., Meremikwu, M., Miller, S., Nabhan, A., Nagai, M., Wahabi, H., & Walker, D. (2022). World Health Organization recommendation for using uterine balloon tamponade to treat postpartum hemorrhage. Obstetrics & Gynecology, 139(3), 458-462.
https://doi.org/10.1097/aog.0000000000004674
11. Finlayson, K., Vogel, J. P., Althabe, F., Widmer, M., & Oladapo, O. T. (2021). Healthcare providers experiences of using uterine balloon tamponade (UBT) devices for the treatment of post-partum haemorrhage: A meta-synthesis of qualitative studies. PLOS ONE, 16(3), e0248656.
https://doi.org/10.1371/journal.pone.0248656
12. León, W., Durocher, J., Barrera, G., Pinto, E., & Winikoff, B. (2012). Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: What difference do they make? BMC Pregnancy and Childbirth, 12(1).
https://doi.org/10.1186/1471-2393-12-65
13. DOUMOUCHTSIS, S. K., PAPAGEORGHIOU, A. T., VERNIER, C., & ARULKUMARAN, S. (2008). Management of postpartum hemorrhage by uterine balloon tamponade: Prospective evaluation of effectiveness. Acta Obstetricia et Gynecologica Scandinavica, 87(8), 849-855.
https://doi.org/10.1080/00016340802179822
14. Chandrakar, S., Markam, D., Sharma, S., N, & Singh, R. P. (2023). Comparing the effectiveness of JH balloon tamponade and Foley's condom balloon tamponade in preventing atonic postpartum hemorrhage: a study from NSCB Medical College, Jabalpur. Int J Pharm Clin Res, 15(5), 1681-1687.
https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue5,Article212.pdf
15. Akhtar, R., & Afzal, I. (2022). Appraisal of Foley’s catheter as intra-uterine balloon tamponade in controlling post-partum hemorrhage. The Professional Medical Journal, 29(09), 1338-1342.
https://doi.org/10.29309/tpmj/2022.29.09.6834
16. Nipanal, H. V., & Talawar, S. R. (2023). Efficacy of intrauterine balloon tamponade by 24-French Foley catheter in prevention of postpartum hemorrhage. Journal of South Asian Federation of Obstetrics and Gynaecology, 14(6), 649-652.
https://doi.org/10.5005/jp-journals-10006-2139
17. Agrawal, S., & Munir, S. I. (2024). Comparison of efficacy and safety of intrauterine balloon tamponade versus Uterovaginal packing in females presenting with postpartum hemorrhage after normal vaginal delivery. Nepal Medical College Journal, 26(1), 34-38.
https://doi.org/10.3126/nmcj.v26i1.63879
18. Dumont, A., Bodin, C., Hounkpatin, B., Popowski, T., Traoré, M., Perrin, R., & Rozenberg, P. (2017). Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: A randomised controlled trial in Benin and Mali. BMJ Open, 7(9), e016590.
https://doi.org/10.1136/bmjopen-2017-016590
19. Shetty, S. S., Moray, K. V., Sachin, O., Chaurasia, H., & Joshi, B. (2022). A narrative review comparing clinical effectiveness of commonly used uterine balloon tamponade devices for postpartum haemorrhage management in India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 11(10), 2924.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
